Plasma-derived exosomal analysis and deconvolution enables prediction and tracking of melanoma checkpoint blockade response
A. Shi, G. G. Kasumova, W. A. Michaud, J. Cintolo-Gonzalez, J. F. Ohmura, A. Mehta, I. Chien, D. T. Frederick, S. Cohen, D. Plana, D. Johnson, K. T. Flaherty, R. J. Sullivan, M. Kellis, G. M. Boland
This paper uses plasma-derived exosomal RNA to predict and track melanoma response to immune checkpoint inhibitors by analyzing tumor and immune signatures.
bioRxiv · Oct 18, 2019 · PreprintCancer Biology